Why Tech Insiders Are Buying Eli Lilly Stock
Tech experts usually buy software stocks, but now they are betting on Eli Lilly.
Tech leaders usually bet on computer chips and artificial intelligence. Jim Cramer found a surprise when he asked industry insiders for their favorite stock. They pointed away from Silicon Valley and chose healthcare giant Eli Lilly.
Eli Lilly makes popular treatments for diabetes and weight loss. Doctors cannot write prescriptions fast enough to meet demand. Wall Street analysts believe the drugmaker could cross a two trillion dollar valuation in the coming years.
Tech leaders love high growth. They see Eli Lilly as a winner because health needs are rising across the globe. The company continues to build new factories to supply more medicine to patients.
You do not need a computer science degree to spot major trends. Great growth often hides outside the tech sector. Eli Lilly shows that medical breakthroughs can create lasting value for everyday investors.
Source: CNBC
More from Biotech
